Tracking the launch and progression of innovative drugs entering clinical trials in China is a daunting task for biopharmaceutical firms aiming to assess and monitor this rapidly growing market. With this edition, BioWorld Asia introduces what will be a regular source of this vital information: China clinical trials update, below.